| pubmed-article:8056578 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8056578 | lifeskim:mentions | umls-concept:C0003402 | lld:lifeskim |
| pubmed-article:8056578 | lifeskim:mentions | umls-concept:C0220641 | lld:lifeskim |
| pubmed-article:8056578 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
| pubmed-article:8056578 | lifeskim:mentions | umls-concept:C0052762 | lld:lifeskim |
| pubmed-article:8056578 | lifeskim:mentions | umls-concept:C0771004 | lld:lifeskim |
| pubmed-article:8056578 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:8056578 | lifeskim:mentions | umls-concept:C1568868 | lld:lifeskim |
| pubmed-article:8056578 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:8056578 | pubmed:dateCreated | 1994-9-13 | lld:pubmed |
| pubmed-article:8056578 | pubmed:abstractText | One of the dose-limiting adverse effects of chemoradiotherapy is mucositis, especially oral mucositis. Prophylaxis of severe mucosal reaction would allow application of aggressive chemoradiotherapy to malignancies. | lld:pubmed |
| pubmed-article:8056578 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8056578 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8056578 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8056578 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8056578 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8056578 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8056578 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8056578 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8056578 | pubmed:issn | 1043-3074 | lld:pubmed |
| pubmed-article:8056578 | pubmed:author | pubmed-author:YamamotoTT | lld:pubmed |
| pubmed-article:8056578 | pubmed:author | pubmed-author:YonedaKK | lld:pubmed |
| pubmed-article:8056578 | pubmed:author | pubmed-author:HirotaJJ | lld:pubmed |
| pubmed-article:8056578 | pubmed:author | pubmed-author:OsakiTT | lld:pubmed |
| pubmed-article:8056578 | pubmed:author | pubmed-author:UetaEE | lld:pubmed |
| pubmed-article:8056578 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8056578 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:8056578 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8056578 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8056578 | pubmed:pagination | 331-9 | lld:pubmed |
| pubmed-article:8056578 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:meshHeading | pubmed-meshheading:8056578-... | lld:pubmed |
| pubmed-article:8056578 | pubmed:articleTitle | Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by Azelastine hydrochloride (Azelastine) with other antioxidants. | lld:pubmed |
| pubmed-article:8056578 | pubmed:affiliation | Department of Oral Surgery, Kochi Medical School, Japan. | lld:pubmed |
| pubmed-article:8056578 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8056578 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8056578 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8056578 | lld:pubmed |
